Your browser doesn't support javascript.
loading
Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas.
Fusco, Michael J; Piña, Yolanda; Macaulay, Robert J; Sahebjam, Solmaz; Forsyth, Peter A; Peguero, Edwin; Walko, Christine M.
Affiliation
  • Fusco MJ; Department of Individualized Cancer Medicine, 25301Moffitt Cancer Center, Tampa, FL, USA.
  • Piña Y; Department of Neuro-Oncology, 25301Moffitt Cancer Center, Tampa, FL, USA.
  • Macaulay RJ; Department of Neuro-Oncology, 25301Moffitt Cancer Center, Tampa, FL, USA.
  • Sahebjam S; Department of Anatomic Pathology, 25301Moffitt Cancer Center, Tampa, FL, USA.
  • Forsyth PA; Department of Neuro-Oncology, 25301Moffitt Cancer Center, Tampa, FL, USA.
  • Peguero E; Department of Neuro-Oncology, 25301Moffitt Cancer Center, Tampa, FL, USA.
  • Walko CM; Department of Neuro-Oncology, 25301Moffitt Cancer Center, Tampa, FL, USA.
Cancer Control ; 28: 10732748211040013, 2021.
Article in En | MEDLINE | ID: mdl-34620004

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Mitogen-Activated Protein Kinases / Proto-Oncogene Proteins B-raf / Glioma Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Cancer Control Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Mitogen-Activated Protein Kinases / Proto-Oncogene Proteins B-raf / Glioma Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Cancer Control Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: